AstraZeneca Shares Fall on Deal Talks With Bristol-Myers - Bloomberg
- AstraZeneca Shares Fall on Deal Talks With Bristol-Myers Bloomberg
- AstraZeneca slides after report of Bristol Myers merger talks leaves analysts 'perplexed' CNBC
- AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled. MarketWatch
- Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea Fierce Pharma
- AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says Reuters
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events